125 related articles for article (PubMed ID: 34493196)
1. Predictors of Avascular Necrosis in a Cohort of Egyptian Systemic Lupus Erythematosus Patients: Retrospective Two Centers Study.
Moghazy AA; Ibrahim AM
Curr Rheumatol Rev; 2022; 18(2):144-149. PubMed ID: 34493196
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
[TBL] [Abstract][Full Text] [Related]
4. Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus.
Al Saleh J; El Sayed M; Salah N; Harb D; Khan N; Mohammed N
Egypt J Immunol; 2010; 17(1):29-40. PubMed ID: 22053607
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities among Egyptian systemic lupus erythematosus: The COMOSLE-EGYPT study.
Gamal SM; Mokbel A; Niazy MH; Elgengehy FT; Elsaid NY; Fouad NA; Sobhy N; Tantawy M; Mohamed SS; Ghaleb RM; Abdelaleem EA; El-Zorkany B
Chronic Illn; 2023 Dec; 19(4):791-803. PubMed ID: 36373605
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII.
Cheng C; Huang C; Chen Z; Zhan F; Duan X; Wang Y; Zhao C; Wu Z; Xu J; Li H; Yang M; Wu R; Zhao J; Zhang S; Wang Q; Leng X; Tian X; Li M; Zeng X
Arthritis Res Ther; 2023 May; 25(1):78. PubMed ID: 37173771
[TBL] [Abstract][Full Text] [Related]
7. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.
Faezi ST; Hoseinian AS; Paragomi P; Akbarian M; Esfahanian F; Gharibdoost F; Akhlaghi M; Nadji A; Jamshidi AR; Shahram F; Nejadhosseinian M; Davatchi F
Mod Rheumatol; 2015 Jul; 25(4):590-4. PubMed ID: 25528860
[TBL] [Abstract][Full Text] [Related]
8. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
Tse SM; Mok CC
Lupus; 2017 Jun; 26(7):715-722. PubMed ID: 27831540
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
Shaharir SS; Chua SH; Mohd R; Mustafar R; Noh MM; Shahril NS; Said MSM; Rajalingham S
PLoS One; 2021; 16(3):e0248845. PubMed ID: 33739994
[TBL] [Abstract][Full Text] [Related]
10. Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid.
Doğan I; Kalyoncu U; Kiliç L; Akdoğan A; Karadağ Ö; Kiraz S; Bilgen ŞA; Ertenli I
Turk J Med Sci; 2020 Feb; 50(1):219-224. PubMed ID: 31905492
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
Yang Y; Kumar S; Lim LS; Silverman ED; Levy DM
J Rheumatol; 2015 Dec; 42(12):2304-9. PubMed ID: 26568601
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.
Sayarlioglu M; Yuzbasioglu N; Inanc M; Kamali S; Cefle A; Karaman O; Onat AM; Avan R; Cetin GY; Gul A; Ocal L; Aral O
Rheumatol Int; 2012 Jan; 32(1):177-82. PubMed ID: 20711782
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for avascular bone necrosis in systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
Br J Rheumatol; 1998 Aug; 37(8):895-900. PubMed ID: 9734682
[TBL] [Abstract][Full Text] [Related]
14. Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
A Mohammed RH; Lotfy Fayed H; Ibrahim Emara N
Lupus; 2022 Apr; 31(5):628-636. PubMed ID: 35306918
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors.
Nevskaya T; Gamble MP; Pope JE
Clin Exp Rheumatol; 2017; 35(4):700-710. PubMed ID: 28240590
[TBL] [Abstract][Full Text] [Related]
16. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
17. The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.
Hou R; Lei J; Xue D; Jing Y; Mi L; Guo Q; Xu K; Zhang L
Front Immunol; 2024; 15():1288234. PubMed ID: 38384449
[TBL] [Abstract][Full Text] [Related]
18. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
19. The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.
Zhu KK; Xu WD; Pan HF; Zhang M; Ni J; Ge FY; Ye DQ
Inflammation; 2014 Oct; 37(5):1852-64. PubMed ID: 24862229
[TBL] [Abstract][Full Text] [Related]
20. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR
J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
